1. Home
  2. MAIA vs WYY Comparison

MAIA vs WYY Comparison

Compare MAIA & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • WYY
  • Stock Information
  • Founded
  • MAIA 2018
  • WYY 1991
  • Country
  • MAIA United States
  • WYY United States
  • Employees
  • MAIA N/A
  • WYY N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • WYY EDP Services
  • Sector
  • MAIA Health Care
  • WYY Technology
  • Exchange
  • MAIA Nasdaq
  • WYY Nasdaq
  • Market Cap
  • MAIA 52.7M
  • WYY 54.9M
  • IPO Year
  • MAIA 2022
  • WYY 1998
  • Fundamental
  • Price
  • MAIA $1.98
  • WYY $5.00
  • Analyst Decision
  • MAIA
  • WYY Strong Buy
  • Analyst Count
  • MAIA 0
  • WYY 1
  • Target Price
  • MAIA N/A
  • WYY $7.00
  • AVG Volume (30 Days)
  • MAIA 175.0K
  • WYY 151.2K
  • Earning Date
  • MAIA 11-12-2024
  • WYY 11-13-2024
  • Dividend Yield
  • MAIA N/A
  • WYY N/A
  • EPS Growth
  • MAIA N/A
  • WYY N/A
  • EPS
  • MAIA N/A
  • WYY N/A
  • Revenue
  • MAIA N/A
  • WYY $133,124,648.00
  • Revenue This Year
  • MAIA N/A
  • WYY $25.94
  • Revenue Next Year
  • MAIA N/A
  • WYY $13.22
  • P/E Ratio
  • MAIA N/A
  • WYY N/A
  • Revenue Growth
  • MAIA N/A
  • WYY 31.67
  • 52 Week Low
  • MAIA $0.95
  • WYY $1.83
  • 52 Week High
  • MAIA $5.99
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 45.13
  • WYY 49.34
  • Support Level
  • MAIA $1.93
  • WYY $4.70
  • Resistance Level
  • MAIA $2.63
  • WYY $5.80
  • Average True Range (ATR)
  • MAIA 0.20
  • WYY 0.48
  • MACD
  • MAIA 0.03
  • WYY -0.11
  • Stochastic Oscillator
  • MAIA 37.37
  • WYY 21.08

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.

Share on Social Networks: